sorafenib has been researched along with mannitol in 3 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (mannitol) | Trials (mannitol) | Recent Studies (post-2010) (mannitol) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 13,114 | 685 | 2,583 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baumgärtner, W; Gerhauser, I; Koraka, P; Martina, BEE; Marzec, A; Orlowska, A; Osterhaus, ADME; Roose, JM; Smreczak, M; Trebas, P; Wohlsein, P; Zmudzinski, J | 1 |
| El-Kholy, AA; Esawie, M; Hasanin, AH; L Louka, M; Said Ali, H | 1 |
1 review(s) available for sorafenib and mannitol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for sorafenib and mannitol
| Article | Year |
|---|---|
Combination drug treatment prolongs survival of experimentally infected mice with silver-haired bat rabies virus.
Topics: Animals; Apoptosis; Brain; Cell Line, Tumor; Chiroptera; Female; Infliximab; Mannitol; Mice; Mice, Inbred C57BL; Post-Exposure Prophylaxis; Pyroptosis; Rabies; RNA, Viral; Sorafenib; Spinal Cord | 2019 |
High-glucose-induced hyperosmolar stress sensitizes HepG2 cell lines to sorafenib.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Proliferation; Glucose; Hep G2 Cells; Humans; Liver Neoplasms; Mannitol; RNA, Long Noncoding; Sorafenib | 2022 |